Market Place
Sourcing Support
UCB To Share BIMZELX Two-Year Data In Arthritis At EULAR 2024
12 Jun 2024 //
PR NEWSWIRE
Cue Biopharma Doses First Patient in Phase 1 Study of CUE-102
22 Aug 2022 //
GLOBENEWSWIRE
NeoImmuneTech Begins Dosing in Phase 1b Study of NT-I7 and Kymriah in r/rLBCL
13 Oct 2021 //
BUSINESSWIRE
Calypso Biotech Announces First Patient dosed with CALY-002
09 Sep 2021 //
BUSINESSWIRE
Selecta & Cyrus Biotech. Collaborate for Novel Engineered Therapeutic Proteins
08 Sep 2021 //
GLOBENEWSWIRE
Synthekine Launches with $82 Million Series A Financing to Advance Pipeline
17 Sep 2020 //
BIOSPACE
Eli Lilly`s $1.6B cancer drug failed to spark even slightest positive gain
24 Jan 2020 //
END PTS
Leo Pharma enters the prize-fight ring with +VE PhIII atopic dermatitis data
11 Dec 2019 //
BUSINESSWIRE
After Cancer Drug Fails Pancreatic Cancer Trial, Lilly Plans to Continue Studies
17 Oct 2019 //
BIOSPACE
Lilly`s Armo buyout drug a bust in pancreatic cancer
17 Oct 2019 //
FIERCE BIOTECH
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee
16 Oct 2019 //
BUSINESSNEWSWIRE
Treating glioblastoma with a drug-induced IL-12 gene therapy
14 Aug 2019 //
FIERCE BIOTECH
Eli Lilly shows new signs of life with $40M cash discovery deal for NextCure
06 Nov 2018 //
ENDPTS
RELIEF THERAPEUTICS Holding SA Announces an Out-Licensing Agreement with H&H Group
13 Sep 2018 //
BUSINESSWIRE
FiercePharmaAsia—Sanofi, Takeda, I-Mab and more
06 Jul 2018 //
FIERCE PHARMA
Shkreli in the stocks; still sharing biotech tips
03 Jul 2018 //
FIERCE BIOTECH
I-Mab closes one of China’s biggest bio fundraisings
03 Jul 2018 //
FIERCE BIOTECH
Cell-in-a-Box encapsulated cells to produce interleukin-2
26 Jun 2018 //
BIOSPECTRUM
Next-Generation Therapies in Focus at Year`s Top Cancer Meeting
01 Jun 2018 //
BLOOMERG
Genexine inks licensing pact with I-Mab Biopharma develop immuno-oncology drug
27 Dec 2017 //
PHARMABIZ
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
26 Dec 2017 //
PR NEWSWIRE
United Therapeutic`s Unituxin (Dinutuximab) Approved in EU For Neuroblastoma
02 Sep 2015 //
EMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.